Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2025-12-25 @ 1:40 PM
NCT ID: NCT05683392
Description: None
Frequency Threshold: 0
Time Frame: Two weeks for each intervention.
Study: NCT05683392
Study Brief: Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Lower Range Participants will use t:slim X2 insulin pump with Control-IQ technology 2.0 with a lower range for two weeks. 0 None 0 72 6 72 View
Standard Range Participants will use t:slim X2 insulin pump with Control-IQ technology 2.0 with a lower range for two weeks. 0 None 0 72 15 72 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Urinary Tract Infection SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (Unspecified) View
Hyperglycemia without ketosis SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA (Unspecified) View
Hyperglycemia with ketosis SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA (Unspecified) View
Foot Injury SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Yeast Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Skin Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Upper Respiratory Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Pain SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (Unspecified) View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Sprained Ankle SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Otitis Media SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View